Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.340,22
0,01%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alimera Sciences Inc (ALIM) Alimera Sciences Inc (ALIM) Notizie

Alimera Sciences Inc

ALIM
2,96
0,04 (1,37%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/6/202422:30GLOBEAlimera Sciences Reports Inducement Grants Under Nasdaq..
16/5/202423:06EDGAR2Form SC 13D/A - General statement of acquisition of..
14/5/202423:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202414:46EDGAR2Form 8-K - Current report
14/5/202413:30GLOBEAlimera Sciences Reports First Quarter 2024 Results
07/5/202414:00GLOBEAlimera Announces Scientific Data Highlighting YUTIQ® to be..
30/4/202414:00GLOBEAlimera Sciences to Report First Quarter 2024 Financial..
20/3/202413:00GLOBEAlimera Sciences Reports Inducement Grants Under Nasdaq..
19/3/202413:00GLOBEAlimera Announces First Patient Randomized in Radiation..
08/3/202423:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202414:32EDGAR2Form 8-K - Current report
07/3/202413:30GLOBEAlimera Sciences Reports Fourth Quarter and Full Year 2023..
29/2/202414:00GLOBEAlimera Sciences to Report Fourth Quarter and Full Year 2023..
13/2/202422:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202421:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202423:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/2/202423:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/2/202423:08EDGAR2Form 8-K - Current report
08/2/202414:00GLOBEThe UK National Institute for Health and Care Excellence..
11/1/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202422:01EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEAlimera Completes Recruitment for the Synchronicity Study
02/1/202414:00GLOBEAlimera Sciences Names Elliot Maltz as Chief Financial..
13/12/202323:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202323:09EDGAR2Form 8-K - Current report
12/12/202313:30GLOBEAlimera Sciences Appoints Todd Wood as President of U.S...
28/11/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202323:18EDGAR2Form 8-K - Current report
08/11/202322:30GLOBEAlimera Appoints Maggie A. Pax to Its Board of Directors
31/10/202313:00GLOBEAlimera Announces Scientific Data Highlighting ILUVIEN® To..
26/10/202313:39EDGAR2Form 8-K - Current report
26/10/202313:00GLOBEAlimera Sciences Reports Third Quarter 2023 Results
16/10/202314:00GLOBEAlimera Sciences to Report Third Quarter 2023 Financial..
11/10/202314:00GLOBEAlimera Announces Multiple Presentations Highlighting..
04/10/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202314:00GLOBEAlimera Sciences Appoints Jason Werner as Chief Operating..
03/10/202313:00EDGAR2Form 8-K - Current report
15/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,92 Min: 2,92 Max: 3,04
Chiusura: 2,92

La tua Cronologia

NASDAQ
ALIM
Alimera Sciences
ASX
BHPKOQ
NASDAQ
WFFBBX
Flex Focus Aggressive 20...
LSE
EQQQ
Inv Nasdaq 100
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network